Swislocki Arthur L M, Wexler Jason A
Medical Service, Department of Veterans Affairs, Northern California Health Care System, Martinez, California 94553, USA.
Endocr Pract. 2007 Mar-Apr;13(2):194-7. doi: 10.4158/EP.13.2.194.
To review the history of the transition of bisphosphonate use from bench chemistry to clinical applications.
Pertinent medical literature, including limited-distribution as well as peer-reviewed publications, was reviewed.
Bisphosphonates were originally developed to interfere with calcium deposition. An expanded understanding of bone physiology, as well as a growing appreciation of bisphosphonate chemistry, allowed a broadening range of clinical applications.
The use of bisphosphonates in clinical medicine depended on a series of fortuitous events that, at the time, were "stumbles," not unlike the discoveries of Fleming and Newton. The logical sequence is more apparent in retrospect.
回顾双膦酸盐从实验室化学研究到临床应用的转变历程。
查阅了相关医学文献,包括发行范围有限的文献以及同行评议的出版物。
双膦酸盐最初是为干扰钙沉积而研发的。对骨生理学认识的扩展以及对双膦酸盐化学性质的深入了解,使得其临床应用范围得以拓宽。
双膦酸盐在临床医学中的应用依赖于一系列偶然事件,这些事件在当时是“意外发现”,与弗莱明和牛顿的发现并无不同。回顾起来,其逻辑顺序更为明显。